Hemostemix Inc. announced that as announced by the company on January 5 and January 6, 2017, Messers. Robert Bard, Victor Redekop and Robert L. Buckler have all resigned as directors of the company, creating three vacancies on the company's board of directors. The remaining director of the company, Angus Jenkins, has appointed Messers. David L. Wood and Donald E. Friesen to fill two of the three vacancies on the board. The newly reconstituted board confirmed that Angus Jenkins will continue to serve as chair of the board. In addition, the board re-established the company's audit committee and corporate governance and compensation committee, with all three of the current directors serving on both committees and Mr. David L. Wood serving as chair of both committees. Also in accordance with the management agreement, the board has appointed Mr. Kyle Makofka as chief restructuring officer. Mr. Makofka is currently the managing director of Drive Capital Corp. (founded in 2012). In the past 27 years, Mr. Makofka has been founder, partner or senior manager in 8 different companies that have led him to operations in over 14 different countries.